In the present study, a correlation between PDGFRA gain/amplification and CDKN2A homozygous loss was seen, and might imply that astrocytoma with alteration of PDGFR is associated with “RTK I” GBM. The gene discussed is CDKN2A; the disease is astrocytoma (excluding glioblastoma).